Company / Named in our posts
Crescent Biopharma, Inc..
Follow Crescent Biopharma, Inc.Crescent Biopharma researches and develops cancer therapy candidates and novel therapies for solid tumors.[1]
01Deal
Deals on Carrywatch
Every deal that names Crescent Biopharma, Inc., and its role in each.
GlycoMimetics, Inc. / Crescent Biopharma, Inc.
GlycoMimetics and Crescent Biopharma complete merger to form combined company
See deal detailsDeal Web
Crescent Biopharma, Inc. and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
5 fiscal years of figures as Crescent Biopharma, Inc. reported them.
News
Loading headlines.
Sources
As of 25 Oct 2026.
- 01Exhibit 99.2—Crescent Biopharma, Inc. Condensed Financial Statements (Unaudited)
U.S. Securities and Exchange Commission · Researched 25 Oct 2026
Deal posts naming Crescent Biopharma, Inc.:
- P01